de Bono DP - Search Results

1

Galectin 1 is involved in vascular smooth muscle cell proliferation.

Moiseeva EP, Javed Q, Spring EL, de Bono DP. Moiseeva EP, et al. Among authors: de bono dp. Cardiovasc Res. 2000 Jan 14;45(2):493-502. doi: 10.1016/s0008-6363(99)00276-x. Cardiovasc Res. 2000. PMID: 10728371

2

Galectin 1 modulates attachment, spreading and migration of cultured vascular smooth muscle cells via interactions with cellular receptors and components of extracellular matrix.

Moiseeva EP, Spring EL, Baron JH, de Bono DP. Moiseeva EP, et al. Among authors: de bono dp. J Vasc Res. 1999 Jan-Feb;36(1):47-58. doi: 10.1159/000025625. J Vasc Res. 1999. PMID: 10050073

3

Inhibition of vascular smooth muscle cell adhesion and migration by c7E3 Fab (abciximab): a possible mechanism for influencing restenosis.

Baron JH, Moiseeva EP, de Bono DP, Abrams KR, Gershlick AH. Baron JH, et al. Among authors: de bono dp. Cardiovasc Res. 2000 Dec;48(3):464-72. doi: 10.1016/s0008-6363(00)00201-7. Cardiovasc Res. 2000. PMID: 11090842

4

Genetic identification of antigens exposed in damaged endothelial cells as laminin-binding proteins.

Ireland DC, Spring EL, Moiseeva E, de Bono DP. Ireland DC, et al. Among authors: de bono dp. Clin Exp Immunol. 1998 May;112(2):255-61. doi: 10.1046/j.1365-2249.1998.00567.x. Clin Exp Immunol. 1998. PMID: 9649188 Free PMC article.

5

Plasminogen activator and plasminogen activator inhibitor gene expression in human saphenous vein organ culture.

Javed Q, Swanson N, Warner EL, Gershlick AH, de Bono DP. Javed Q, et al. Among authors: de bono dp. Exp Mol Pathol. 2001 Apr;70(2):146-53. doi: 10.1006/exmp.2000.2352. Exp Mol Pathol. 2001. PMID: 11263957

6

Changes in vessel wall plasminogen activator activity and smooth muscle cell proliferation and activation after arterial injury.

More RS, Underwood MJ, Brack MJ, de Bono DP, Gershlick AH. More RS, et al. Among authors: de bono dp. Cardiovasc Res. 1995 Jan;29(1):22-6. Cardiovasc Res. 1995. PMID: 7895234

7

In vitro evaluation of c7E3-Fab (ReoPro) eluting polymer-coated coronary stents.

Baron JH, Gershlick AH, Hogrefe K, Armstrong J, Holt CM, Aggarwal RK, Azrin M, Ezekowitz M, de Bono DP. Baron JH, et al. Among authors: de bono dp. Cardiovasc Res. 2000 Jun;46(3):585-94. doi: 10.1016/s0008-6363(00)00042-0. Cardiovasc Res. 2000. PMID: 10912469

8

Increased fibrinolytic activity in the intima of atheromatous coronary arteries: protection at a price.

Underwood MJ, De Bono DP. Underwood MJ, et al. Among authors: de bono dp. Cardiovasc Res. 1993 May;27(5):882-5. doi: 10.1093/cvr/27.5.882. Cardiovasc Res. 1993. PMID: 8348588

9

Effects of N-methyl hexanoylhydroxamic acid (NMHH) and myoglobin on endothelial damage by hydrogen peroxide.

de Bono DP, Yang WD, Davies MJ, Collis CS, Rice Evans CA. de Bono DP, et al. Cardiovasc Res. 1994 Nov;28(11):1641-6. doi: 10.1093/cvr/28.11.1641. Cardiovasc Res. 1994. PMID: 7842457

10

Effect of locally applied tissue-type plasminogen activator on venous fibrinolytic activity: in vitro and in vivo investigations.

Underwood MJ, More RS, Gershlick AH, de Bono DP. Underwood MJ, et al. Among authors: de bono dp. Cardiovasc Res. 1993 Dec;27(12):2270-3. doi: 10.1093/cvr/27.12.2270. Cardiovasc Res. 1993. PMID: 8313438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters